NEW YORK, Jan. 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, has today announced that it has been invited to present at the 24th annual Institutional Investor Conference ("the conference") hosted by The Wall Street Analyst Forum. The conference will take place in New York City at The University Club (located at 1 West 54th Street) on March 03, 2014. Presenting on behalf of Tauriga will be its Chief Executive Officer, Seth M. Shaw, and its Chief Operating Officer, Dr. Stella M. Sung.
The conference is a two day, three track conference featuring 60 presenting public companies. It is attended by several hundred portfolio managers ( http://www.analyst-conference.com/analyst-por...ttendance/ ) and analysts in person and several hundred other investors via webcast. Tauriga Sciences Inc. will deliver a 40 minute corporate presentation and Q & A followed by a 40 minute breakout session in a separate conference room. The breakout session is an opportunity for investors to meet with the Company for a more in depth question and answer session.
Tauriga's CEO Seth M. Shaw, expressed, "Tauriga Sciences is excited to have received an invitation to present at such a high profile investor conference with significant coverage. The Company is working hard to build its future fundamentals and believes this conference will provide it with an outstanding opportunity to enhance its audience, specifically institutional investors."
On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at ( www.tauriga.com ).
About Pilus Energy LLC
A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, ( www.pilusenergy.com ).
About The Wall Street Analyst Forum
Since 1989, The Wall Street Analyst Forum has sponsored over 80 analyst conferences for NYSE/NASDAQ/AMEX corporations in New York, Boston & London. Over 2,200 different public corporations have presented and analysts & portfolio managers from over 2000 different institutions have attended in person & via webcast. Please see the company website at: www.analyst-conference.com
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
For further information regarding Tauriga Sciences, Inc.: Mr. Seth M. Shaw Chairman & Chief Executive Officer Tauriga Sciences, Inc. www.tauriga.com New York: +1-917-796-9926 Montreal: +1-514-840-3697 Email:
